CHRNG genotype-phenotype correlations in the multiple pterygium syndromes

Julie Vogt, Neil Morgan, P Rehal, L Faivre, Louise Brueton, K Becker, JP Fryns, S Holder, L Islam, E Kivuva, SA Lynch, R Touraine, LC Wilson, Fiona MacDonald, Eamonn Maher

Research output: Contribution to journalArticle

28 Citations (Scopus)


Background Germline mutations in the CHRNG gene that encodes the g subunit of the embryonal acetylcholine receptor may cause the non-lethal Escobar variant (EVMPS) or the lethal form (LMPS) of multiple pterygium syndrome (MPS). In addition CHRNG mutations and mutations in other components of the embryonal acetylcholine receptor may present with fetal akinesia deformation sequence (FADS) without pterygia. Methods In order to elucidate further the role of CHRNG mutations in MPS/FADS, this study evaluated the results of CHRNG mutation analysis in 100 families with a clinical diagnosis of MPS/FADS. Results CHRNG mutations were identified in 11/41 (27%) of families with EVMPS and 5/59 (8%) with LMPS/FADS. Most patients with a detectable CHRNG mutation (21 of 24 (87.5%)) had pterygia but no CHRNG mutations were detected in the presence of central nervous system anomalies. Discussion The mutation spectrum was similar in EVMPS and LMPS/FADS kindreds and EVMPS and LMPS phenotypes were observed in different families with the same CHRNG mutation. Despite this intrafamilial variability, it is estimated that there is a 95% chance that a subsequent sibling will have the same MPS phenotype (EVMPS or LMPS) as the proband (though concordance is less for more distant relatives). Based on these findings, a molecular genetic diagnostic pathway for the investigation of MPS/FADS is proposed.
Original languageEnglish
Pages (from-to)21-26
Number of pages6
JournalJournal of Medical Genetics
Issue number1
Publication statusPublished - 1 Jan 2012


Dive into the research topics of 'CHRNG genotype-phenotype correlations in the multiple pterygium syndromes'. Together they form a unique fingerprint.

Cite this